BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Tumor necrosis factor-alpha
1
Tumor necrosis factor-α inhibition restores matrix formation by human adipose-derived stem cells in the late stage of chondrogenic differentiation
11/25/2022 11:36:34 AM | Browse: 209 | Download: 428
2
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 1158 | Download: 1360
3
Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies
3/13/2017 7:05:00 PM | Browse: 1136 | Download: 1666
4
Association of NFKB1 gene polymorphism (rs28362491) with levels of inflammatory biomarkers and susceptibility to diabetic nephropathy in Asian Indians
2/15/2017 11:49:00 AM | Browse: 932 | Download: 1258
5
Role of leptin in the progression of psoriatic, rheumatoid and osteoarthritis
3/11/2016 10:58:00 AM | Browse: 1030 | Download: 1665
6
Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea
12/9/2015 5:57:00 PM | Browse: 1176 | Download: 1641
7
How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?
10/23/2015 3:58:00 PM | Browse: 916 | Download: 1127
8
Phycocyanobilin accelerates liver regeneration and reduces mortality rate in carbon tetrachloride-induced liver injury mice
5/18/2015 5:02:00 PM | Browse: 955 | Download: 1599
9
Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab
9/16/2014 6:10:00 PM | Browse: 1068 | Download: 755
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345